Urinary tract infection is one of the common infections in the Indian community. Distribution and susceptibility of UTI-causing pathogens change according to time and place. This study was conducted to determine the distribution and antimicrobial susceptibility of uropathogens in the Indian community as well as to determine the effect of gender and age on the etiology of bacterial uropathogens. Clean catch midstream urine samples were collected from 288 patients of the age ranging from 15 to ≥48 years. Antimicrobial susceptibility was performed on all isolated bacteria by Kirby Bauer’s disc diffusion method. The multiple antibiotic resistance (MAR) index of each antibiotic was calculated. The UTI prevalence was 53.82% in patients; however, the prevalence was significantly higher in females than in males (females: 73.57%; males: 35.14%; ). Females within the age group of 26–36 years and elderly males of ≥48 years showed higher prevalence of UTI. Gram negative bacteria (90.32%) were found in high prevalence than Gram positive (9.68%). Escherichia coli (42.58%) was the most prevalent gram negative isolate. Nitrofurantoin (78.71%) was found the most resistant drug among all uropathogens. Tested carbapenems were found the most susceptible drug against isolated uropathogens which showed 92.26% and 84.52% susceptibility, respectively. 1. Introduction Urinary tract infection (UTI) is the commonest bacterial infectious disease in community practice with a high rate of morbidity and financial cost. It has been estimated that 150 million people were infected with UTI per annum worldwide which costing global economy more than 6 billion US dollars [1]. UTIs is described as a bacteriuria with urinary symptoms [2]. UTI can affect lower and sometimes both lower and upper urinary tracts. The term cystitis has been used to define the lower UTI infection and is characterized by symptoms such as dysuria, frequency, urgency, and suprapubic tenderness. The presence of the lower UTI symptoms does not exclude the upper UTI which is often present in most UTI cases [3]. The treatment of UTI can be classified into uncomplicated and complicated on the basis of their choice of treatment [4]. UTI is more common in females than in males as female urethra structurally found less effective for preventing the bacterial entry [5]. It may be due to the proximity of the genital tract and urethra [6] and adherence of urothelial mucosa to the mucopolysaccharide lining [7]. The other main factors which make females more prone to UTI are pregnancy and sexual activity [8]. In pregnancy, the
References
[1]
C. M. Gonzalez and A. J. Schaeffer, “Treatment of urinary tract infection: what's old, what's new, and what works,” World Journal of Urology, vol. 17, no. 6, pp. 372–382, 1999.
[2]
I. Zelikovic, R. D. Adelman, and P. A. Nancarrow, “Urinary tract infections in children—an update,” Western Journal of Medicine, vol. 157, no. 5, pp. 554–561, 1992.
[3]
J. D. Sobel and D. Kaye, “Urinary tract infections,” in Mandell, Douglas and Bennett's Principles and Practice of Infectious Diseases, G. L. Mandell, J. E. Bennett, and R. Dolin, Eds., pp. 957–985, Churchill Livingstone, Philadelphia, Pa, USA, 7th edition, 2010.
[4]
S. M. Sabra and M. M. Abdel-Fattah, “Epidemiological and microbiological profile of nosocomial infection in Taif hospitals, KSA (2010-2011),” World Journal of Medical Sciences, vol. 7, no. 1, pp. 1–9, 2012.
[5]
J. W. Warren, E. Abrutyn, J. Richard Hebel, J. R. Johnson, A. J. Schaeffer, and W. E. Stamm, “Guidelines for antimicrobial treatment of uncomplicated acute bacterial cystitis and acute pyelonephritis in women,” Clinical Infectious Diseases, vol. 29, no. 4, pp. 745–758, 1999.
[6]
A. J. Schaeffer, N. Rajan, Q. Cao et al., “Host pathogenesis in urinary tract infections,” International Journal of Antimicrobial Agents, vol. 17, no. 4, pp. 245–251, 2001.
[7]
E. E. Akortha and O. K. Ibadin, “Incidence and antibiotic susceptibility pattern of Staphylococcus aureus amongst patients with urinary tract infection (UTI) in UBTH Benin City, Nigeria,” African Journal of Biotechnology, vol. 7, no. 11, pp. 1637–1640, 2008.
[8]
K. C. Arul, K. G. Prakasam, D. Kumar, and M. Vijayan, “A cross sectional study on distribution of urinary tract infection and their antibiotic utilization pattern in Kerala,” International Journal of Research in Pharmaceutical and Biomedical Sciences, vol. 3, no. 3, pp. 1125–1130, 2012.
[9]
M. J. Lucas and F. G. Cunningham, “Urinary infection in pregnancy,” Clinical Obstetrics and Gynecology, vol. 36, no. 4, pp. 855–868, 1993.
[10]
J. W. Warren, J. H. Tenney, and J. M. Hoopes, “A prospective microbiologic study of bacteriuria in patients with chronic indwelling urethral catheters,” Journal of Infectious Diseases, vol. 146, no. 6, pp. 719–723, 1982.
[11]
M. Y. Ebie, Y. T. Kandaki-Olukemi, J. Ayanbadejo, and K. B. Tanyigna, “UTI infections in a Nigerian Military Hospital,” Nigerian Journal of Microbiology, vol. 15, no. 1, pp. 31–37, 2001.
[12]
A. S. Kolawole, O. M. Kolawole, Y. T. Kandaki-Olukemi, S. K. Babatunde, K. A. Durowade, and C. F. Kolawole, “Prevalence of urinary tract infections (UTI) among patients attending Dalhatu Araf Specialist Hospital, Lafia, Nasarawa State, Nigeria,” International Journal of Medicinal Medical Sciences, vol. 1, no. 5, pp. 163–167, 2009.
[13]
I. O. Okonko, L. A. Ijandipe, O. A. Ilusanya et al., “Incidence of urinary tract infection (UTI) among pregnant women in Ibadan, South-Western Nigeria,” African Journal of Biotechnology, vol. 8, no. 23, pp. 6649–6657, 2009.
[14]
B. Foxman and P. Brown, “Epidemiology of urinary tract infections: transmission and risk factors, incidence, and costs,” Infectious Disease Clinics of North America, vol. 17, no. 2, pp. 227–241, 2003.
[15]
J. I. Alós, “Epidemiology and etiology of urinary tract infections in the community. Antimicrobial susceptibility of the main pathogens and clinical significance of resistance,” Enfermedades Infecciosas y Microbiología Clínica, vol. 23, no. 4, pp. 3–8, 2005.
[16]
C. A. M. McNulty, J. Richards, D. M. Livermore et al., “Clinical relevance of laboratory-reported antibiotic resistance in acute uncomplicated urinary tract infection in primary care,” Journal of Antimicrobial Chemotherapy, vol. 58, no. 5, pp. 1000–1008, 2006.
[17]
J. Car, “Urinary tract infections in women: diagnosis and management in primary care,” British Medical Journal, vol. 332, no. 7533, pp. 94–97, 2006.
[18]
D. H. Tambekar, D. V. Dhanorkar, S. R. Gulhane, V. K. Khandelwal, and M. N. Dudhane, “Antibacterial susceptibility of some urinary tract pathogens to commonly used antibiotics,” African Journal of Biotechnology, vol. 5, no. 17, pp. 1562–1565, 2006.
[19]
D. Biswas, P. Gupta, R. Prasad, V. Singh, M. Arya, and A. Kumar, “Choice of antibiotic for empirical therapy of acute cystitis in a setting of high antimicrobial resistance,” Indian Journal of Medical Sciences, vol. 60, no. 2, pp. 53–58, 2006.
[20]
M. Akram, M. Shahid, and A. U. Khan, “Etiology and antibiotic resistance patterns of community-acquired urinary tract infections in J N M C Hospital Aligarh, India,” Annals of Clinical Microbiology and Antimicrobials, vol. 6, article 4, 2007.
[21]
A. Kothari and V. Sagar, “Antibiotic resistance in pathogens causing community-acquired urinary tract infections in India: a multicenter study,” The Journal of Infection in Developing Countries, vol. 2, no. 5, pp. 354–358, 2008.
[22]
J. G. Collee, R. S. Miles, and B. Watt, “Tests for the identification of bacteria,” in Mackie and Mc Artney Practical Medical Microbiology, J. G. Collee, A. G. Fraser, B. P. Marmion, and A. Simmons, Eds., p. 433, Churchill Livingstone, London, UK, 1996.
[23]
B. Foxman, R. Barlow, H. D'Arcy, B. Gillespie, and J. D. Sobel, “Urinary tract infection: self-reported incidence and associated costs,” Annals of Epidemiology, vol. 10, no. 8, pp. 509–515, 2000.
[24]
A. Andreua, J. I. Alós, M. Gobernado, F. Marco, M. De La Rosa, and J. A. García-Rodríguez, “Etiology and antimicrobial susceptibility among uropathogens causing community-acquired lower urinary tract infections: a nationwide surveillance study,” Enfermedades Infecciosas y Microbiología Clínica, vol. 23, no. 1, pp. 4–9, 2005.
[25]
A. W. Bauer, W. M. Kirby, J. C. Sherris, and M. Turck, “Antibiotic susceptibility testing by a standardized single disk method,” American Journal of Clinical Pathology, vol. 45, no. 4, pp. 493–496, 1966.
[26]
Clinical and Laboratory Standards Institute (CLSI), “Document M100-S17. Performance standards for antimicrobial susceptibility testing,” CLSI, 940 West Valley Road, Suite 1400, Wayne, Pennsylvania 19087–1898, USA, 2007.
[27]
M. Jani, S. Shah, and S. Prajapati, “Antibacterial screening and qualitative phytochemical estimation of selected aquatic plants,” Advances in Biological Research, vol. 6, no. 1, pp. 19–23, 2012.
[28]
N. Kashef, G. E. Djavid, and S. Shahbazi, “Antimicrobial susceptibility patterns of community-acquired uropathogens in Tehran, Iran,” The Journal of Infection in Developing Countries, vol. 4, no. 4, pp. 202–206, 2010.
[29]
J. A. Karlowsky, M. E. Jones, C. Thornsberry, I. Critchley, L. J. Kelly, and D. F. Sahm, “Prevalence of antimicrobial resistance among urinary tract pathogens isolated from female outpatients across the US in 1999,” International Journal of Antimicrobial Agents, vol. 18, no. 2, pp. 121–127, 2001.
[30]
V. Rajalakshmi and V. Amsaveni, “Antibiotic susceptibility of bacterial pathogens isolated from diabetic patients,” International Journal of Microbiological Research, vol. 3, no. 1, pp. 30–32, 2012.
[31]
M. Sharifian, A. Karimi, S. R. Tabatabaei, and N. Anvaripour, “Microbial sensitivity pattern in urinary tract infections in children: a single center experience of 1,177 urine cultures,” Japanese Journal of Infectious Diseases, vol. 59, no. 6, pp. 380–382, 2006.
[32]
M. Haghi-Ashteiani, N. Sadeghifard, M. Abedini, S. Soroush, and M. Taheri-Kalani, “Etiology and antibacterial resistance of bacterial urinary tract infections in children's medical center, Tehran, Iran,” Acta Medica Iranica, vol. 45, no. 2, pp. 153–157, 2007.
[33]
F. R. M. Rashedmarandi and M. Saremi, “A survey on urinary pathogens and their antimicrobial susceptibility among patients with significant bacteriuria,” Iranian Journal of Pathology, vol. 3, pp. 191–196, 2008.
[34]
Nedolisa, Bacteriology of Urinary Tract Infection amongst Patients Attending Jos University Teaching Hospital (JUTH)1998 [M.S. thesis], University of Jos, Jos, Nigeria.
[35]
C. C. Ekweozor and T. N. Onyemenen, “Urinary Tract Infection in Ibadan, Nigeria: causative organism and anti-microbial sensitivity pattern,” African Journal of Medical Sciences, vol. 25, pp. 165–169, 1996.
[36]
K. O. Akinyemi, S. A. Alabi, M. A. Taiwo, and E. A. Omonigbehin, “Antimicrobial susceptibility pattern and plasmid profiles of pathogenic bacteria isolated from subjects with urinary tract infections in Lagos, Nigeria,” Nigerian Quarterly Journal of Hospital Medicine, vol. 1, pp. 7–11, 1997.
[37]
E. I. Bigwan and D. Elijah, “Prevalence of Escherichia coli among uropathogens in asymptomatic bacteriuria in a Nigerian Tertiary School in Jos, Nigeria,” International Journal of Biomedical and Advance Research, vol. 4, no. 3, pp. 198–202, 2013.
[38]
M. Dash, S. Padhi, I. Mohanty, P. Panda, and B. Parida, “Antimicrobial resistance in pathogens causing urinary tract infections in a rural community of Odisha, India,” Journal of Family and Community Medicine, vol. 20, no. 1, pp. 20–26, 2013.
[39]
M. Mehta, S. Bhardwaj, and J. Sharma, “Screening of urinary isolates for the prevalence and antimicrobial susceptibility of Enterobacteria other than Escherichia coli,” International Journal of Life Science and Pharma Research, vol. 3, no. 1, pp. 100–104, 2013.
[40]
F. A. Orrett, “Urinary tract infections in general practice in a rural community in South Trinidad,” Saudi Medical Journal, vol. 22, no. 6, pp. 537–540, 2001.
[41]
A. García-Morúa, A. Hernández-Torres, J. L. Salazar-de-Hoyos, R. Jaime-Dávila, and L. S. Gómez-Guerra, “Community acquired urinary tract infection etiology and antibiotic resistance in a Mexican population group,” Revista Mexicana de Urología, vol. 69, pp. 45–48, 2009.
[42]
H. W. Boucher, G. H. Talbot, J. S. Bradley et al., “Bad bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society of America,” Clinical Infectious Diseases, vol. 48, no. 1, pp. 1–12, 2009.
[43]
B. Henry Oladeinde, R. Omoregie, M. Olley, and J. A. Anunibe, “Urinary tract infection in a rural community of Nigeria,” North American Journal of Medical Sciences, vol. 3, no. 2, pp. 75–77, 2011.
[44]
S. Sood and R. Gupta, “Antibiotic resistance pattern of community acquired uropathogens at a tertiary care hospital in Jaipur, Rajasthan,” Indian Journal of Community Medicine, vol. 37, no. 1, pp. 39–44, 2012.
[45]
J. Ochei and A. Kolhatkar, “Diagnosis of infection by specific anatomic sites/antimicrobial susceptibility tests,” in Medical Laboratory Science Theory and Practicereprint, pp. 615–643, 788–798, McGraw-Hill, New Delhi, India, 6th edition, 2007.
[46]
O. A. Aiyegoro, O. O. Igbinosa, I. N. Ogunmwonyi, E. Odjadjaro, O. E. Igbinosa, and A. I. Okoh, “Incidence of urinary tract infections (UTI) among children and adolescents in Ile-Ife, Nigeria,” African Journal of Microbiological Research, vol. 1, pp. 13–19, 2007.
[47]
F. A. Orrett and G. K. Davis, “A comparison of antimicrobial susceptibility profile of urinary pathogens for the years, 1999 and 2003,” West Indian Medical Journal, vol. 55, no. 2, pp. 95–99, 2006.
[48]
T. S. Dimitrov, E. E. Udo, F. Awni, M. Emara, and R. Passadilla, “Etiology and antibiotic susceptibility patterns of community-acquired urinary tract Infections in a Kuwait Hospital,” Medical Principles and Practice, vol. 13, no. 6, pp. 334–339, 2004.
[49]
O. Omigie, L. Okoror, P. Umolu, and G. Ikuuh, “Increasing resistance to quinolones: a four-year prospective study of urinary tract infection pathogens,” International Journal of General Medicine, vol. 2, pp. 171–175, 2009.
[50]
K. Shigemura, K. Tanaka, H. Okada et al., “Pathogen occurrence and antimicrobial susceptibility of urinary tract infection cases during a 20-year period (1983-2002) at a single institution in Japan,” Japanese Journal of Infectious Diseases, vol. 58, no. 5, pp. 303–308, 2005.
[51]
R. N. Das, T. S. Chandrashekhar, H. S. Joshi, M. Gurung, N. Shrestha, and P. G. Shivananda, “Frequency and susceptibility profile of pathogens causing urinary tract infections at a tertiary care hospital in western Nepal,” Singapore Medical Journal, vol. 47, no. 4, pp. 281–285, 2006.
[52]
S. Shankel, Urinary Tract Infections Genitourinary Disorders, The Merck Manuals Online Medical Library, 2007.
[53]
F. A. Orrett and S. M. Shurland, “The changing patterns of antimicrobial susceptibility of urinary pathogens in Trinidad,” Singapore Medical Journal, vol. 39, no. 6, pp. 256–259, 1998.
[54]
A. C. Gales, R. N. Jones, K. A. Gordon et al., “Activity and spectrum of 22 antimicrobial agents tested against urinary tract infection pathogens in hospitalized patients in Latin America: report from the second year of the SENTRY Antimicrobial Surveillance Program (1998),” Journal of Antimicrobial Chemotherapy, vol. 45, no. 3, pp. 295–303, 2000.
[55]
M. Theodore, “Prevalence and antibiogram of urinary tract infections among prison inmates in Nigeria,” The Internet Journal of Microbiology, vol. 3, no. 2, 2007.
[56]
B. A. M. Adedeji and O. A. Abdulkadir, “Etiology and antimicrobial resistance pattern of bacterial agents of urinary tract infections in students of tertiary institution in Yola metropolis,” Advances in Biological Researchno, vol. 3, no. 4, pp. 67–70, 2009.
[57]
A. N. Kebira, P. Ochola, and S. A. Khamadi, “Isolation and antimicrobial susceptibility testing of Escherichia coli causing urinary tract infections,” Journal of Applied Biosciences, vol. 22, pp. 1320–1325, 2009.
[58]
I. Shaifali, U. Gupta, S. E. Mahmood, and J. Ahmed, “Antibiotic susceptibility patterns of urinary pathogens in female outpatients,” North American Journal of Medical Sciences, vol. 4, no. 4, pp. 163–169, 2012.
[59]
T. M. Hooton, D. Scholes, J. P. Hughes et al., “A prospective study of risk factors for symptomatic urinary tract infection in young women,” The New England Journal of Medicine, vol. 335, no. 7, pp. 468–474, 1996.
[60]
E. Kalantar, M. E. Motlagh, H. Lornejad, and N. Reshadmanesh, “Prevalence of urinary tract pathogens and antimicrobial susceptibility patterns in children at hospitals in Iran,” Iranian Journal of Clinical Infectious Diseases, vol. 3, no. 3, pp. 149–153, 2008.
[61]
R. N. Gruneberg, “Antibiotic sensitivities of urinary pathogens, 1971–1978,” Journal of Clinical Pathology, vol. 33, no. 9, pp. 853–856, 1980.
[62]
R. Daza, J. Gutiérrez, and G. Piédrola, “Antibiotic susceptibility of bacterial strains isolated from patients with community-acquired urinary tract infections,” International Journal of Antimicrobial Agents, vol. 18, no. 3, pp. 211–215, 2001.
[63]
E. M. Abubakar, “Antimicrobial susceptibility pattern of pathogenic bacteria causing urinary tract infections at the Specialist Hospital, Yola, Adamawa State, Nigeria,” Journal of Clinical Medicine Research, vol. 1, no. 1, pp. 001–008, 2009.
[64]
J. O. Ehinmidu, R. O. Bolaji, and E. E. A. Adegboye, “Isolation and antibiotic susceptibility profile of Neisseria gonorrhoeae isolated from urine samples in Zaria, northern Nigeria,” Journal of Phytomedicine and Therapeutics, vol. 8-11, pp. 20–24, 2003.
[65]
O. A. Aboderin, L.-R. Abdu, B. W. Odetoyin, and A. Lamikanra, “Antimicrobial resistance in Escherichia coli strains from urinary tract infections,” Journal of the National Medical Association, vol. 101, no. 12, pp. 1268–1273, 2009.
[66]
N. Al Sweih, W. Jamal, and V. O. Rotimi, “Spectrum and antibiotic resistance of uropathogens isolated from hospital and community patients with urinary tract infections in two large hospitals in Kuwait,” Medical Principles and Practice, vol. 14, no. 6, pp. 401–407, 2005.
[67]
J. C. Uwaezuoke and N. Ogbulie, “Antibiotic sensitivity pattern of urinary tract pathogens in Port-Harcourt, Nigeria,” Journal of Applied Sciences and Environmental Management, vol. 10, no. 3, pp. 103–107, 2006.
[68]
B. N. Selvakumar and R. Jasmine, “Antibiotic susceptibility of ESBL-producing urinary isolates at a Tertiary Care Hospital in Tiruchirappalli South India,” Journal of Medical Sciences, vol. 7, no. 3, pp. 443–446, 2007.
[69]
J. Bahadin, S. S. H. Teo, and S. Mathew, “Aetiology of community-acquired urinary tract infection and antimicrobial susceptibility patterns of uropathogens isolated,” Singapore Medical Journal, vol. 52, no. 6, pp. 415–420, 2011.
[70]
K. Bano, J. Khan, R. H. Begum, et al., “Patterns of antibiotic sensitivity of bacterial pathogens among urinary tract infections (UTI) patients in a Pakistani population,” African Journal of Microbiological Research, vol. 6, pp. 414–420, 2012.
[71]
S. Nys, T. van Merode, A. I. M. Bartelds, and E. E. Stobberingh, “Urinary tract infections in general practice patients: diagnostic tests versus bacteriological culture,” Journal of Antimicrobial Chemotherapy, vol. 57, no. 5, pp. 955–958, 2006.
[72]
S. Nys, T. Van Merode, A. I. M. Bartelds, and E. E. Stobberingh, “Antibiotic treatment and resistance of unselected uropathogens in the elderly,” International Journal of Antimicrobial Agents, vol. 27, no. 3, pp. 236–241, 2006.
[73]
S. Nys, “Antibiotic resistance and commensal flora,” in Microbiology, p. 142, University Maastricht, Maastricht, The Netherlands, 2005.
[74]
B. A. Lipsky, “Urinary tract infections in men. Epidemiology, pathophysiology, diagnosis and treatment,” Annals of Internal Medicine, vol. 110, no. 2, pp. 138–150, 1989.
[75]
B. A. Lipsky, “Prostatitis and urinary tract infection in men: what's new; what's true?” American Journal of Medicine, vol. 106, no. 3, pp. 327–334, 1999.
[76]
I. Alipourfard and N. Y. Nili, “Antibiogram of Extended Spectrum Beta-lactamase (ESBL) producing Escherichia coli and Klebsiella pneumoniae isolated from Hospital Samples,” Bangladesh Journal of Medical Microbiologyno, vol. 4, no. 4, pp. 32–36, 2010.
[77]
A. Mangaiarkkarasi, A. R. Meher, and R. Gopal, “Study of Antimicrobial Susceptibility Pattern of Escherichia coli Isolated from clinical specimens in a Teaching Hospital, Pondicherry,” The Research Journal of Pharmaceutical, Biological and Chemical Sciences, vol. 4, no. 1, pp. 1365–1371, 2013.
[78]
N. Goel, U. Chaudhary, R. Aggarwal, and K. Bala, “Antibiotic sensitivity pattern of gram negative bacilli isolated from the lower respiratory tract of ventilated patients in the intensive care unit,” Indian Journal of Critical Care Medicine, vol. 13, no. 3, pp. 148–151, 2009.
[79]
M.-L. Joly-Guillou, M. Kempf, J.-D. Cavallo et al., “Comparative in vitro activity of Meropenem, Imipenem and Piperacillin/tazobactam against 1071 clinical isolates using 2 different methods: a French multicentre study,” BMC Infectious Diseases, vol. 10, article 1471, 2010.
[80]
A. J. Al-Zahran and N. Akhtar, “Susceptibility patterns of extended spectrum beta-lactamase (ESBL)-producing Escherichia coli and Klebsiella pneumoniae isolated in a teaching hospital,” Pakistan Journal of Medical Research, vol. 44, pp. 64–67, 2005.
[81]
M. Gobernado, L. Valdés, J. I. Alós, C. García-Rey, R. Dal-Ré, and J. García-de-Lomas, “Antimicrobial susceptibility of clinical Escherichia coli isolates from uncomplicated cystitis in women over a 1-year period in Spain,” Revista Espa？ola de Quimioterapia, vol. 20, no. 1, pp. 68–76, 2007.
[82]
E. R. Sabharwal, “Antibiotic susceptibility patterns of uropathogens in obstetric patients,” North American Journal of Medical Sciences, vol. 4, pp. 316–319, 2012.
[83]
G. Kahlmeter, “An international survey of the antimicrobial susceptibility of pathogens from uncomplicated urinary tract infections: the ECO.SENS project,” Journal of Antimicrobial Chemotherapy, vol. 51, no. 1, pp. 69–76, 2003.
[84]
W. Goettsch, W. Van Pelt, N. Nagelkerke et al., “Increasing resistance to fluoroquinolones in Escherichia coli from urinary tract infections in The Netherlands,” Journal of Antimicrobial Chemotherapy, vol. 46, no. 2, pp. 223–228, 2000.
[85]
H. Goossens, M. Ferech, R. Vander Stichele, and M. Elseviers, “Outpatient antibiotic use in Europe and association with resistance: a cross-national database study,” The Lancet, vol. 365, no. 9459, pp. 579–587, 2005.
[86]
L. N. McEwen, R. Farjo, and B. Foxman, “Antibiotic prescribing for cystitis: how well does it match published guidelines?” Annals of Epidemiology, vol. 13, no. 6, pp. 479–483, 2003.
[87]
P. H. Krumperman, “Multiple antibiotic resistance indexing of Escherichia coli to identify high-risk sources of fecal contamination of foods,” Applied and Environmental Microbiology, vol. 46, no. 1, pp. 165–170, 1983.
[88]
K. A. Burbige, A. B. Retic, A. Colony, S. B. Bauer, and R. Lebowitz, “UTI in boys,” Journal of Urolology, vol. 132, pp. 541–542, 1984.
[89]
G. N. Manjunath, R. Prakash, V. Annam, and K. Shetty, “The changing trends in the spectrum of the antimicrobial drug resistance pattern of uropathogens which were isolated from hospitals and community patients with urinary tract infections in Tumkur and Bangalore,” International Journal of Biological and Medical Research, vol. 2, no. 2, pp. 504–550, 2011.
[90]
J. Rodríguez-Ba？o, M. D. Navarro, L. Romero et al., “Epidemiology and clinical features of infections caused by extended-spectrum beta-lactamase-producing Escherichia coli in nonhospitalized patients,” Journal of Clinical Microbiology, vol. 42, no. 3, pp. 1089–1094, 2004.
